Search research articles
Contact Us
Filters
Showing results (91-100 of 183) with videos related to
Page
of 19
Sort By:
British Journal of Cancer
|
January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
T E Hutson, R M Bukowski, B I Rini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2026
Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up<sup>†</sup>
E de Azambuja, C H Barrios, R Bartsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
Jens Huober, Carlos H Barrios, Naoki Niikura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
The Lancet. Oncology
|
December 2, 2019
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid, Hope S Rugo, Sylvia Adams, et al.
ESMO Open
|
January 28, 2026
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer
K L Jhaveri, N M Iyengar, N C Turner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
Cora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Plos One
|
August 28, 2018
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, et al.
Journal of the National Cancer Institute
|
February 1, 2021
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study
Leisha A Emens, Luciana Molinero, Sherene Loi, et al.
Journal of Global Oncology
|
November 27, 2019
Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational Study
Max S Mano, Rafaela Gomes, Gustavo Werutsky, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 183) with videos related to
Sort By:
Page
of 19
British Journal of Cancer
|
January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
T E Hutson, R M Bukowski, B I Rini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2026
Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up<sup>†</sup>
E de Azambuja, C H Barrios, R Bartsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2022
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial
Jens Huober, Carlos H Barrios, Naoki Niikura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
The Lancet. Oncology
|
December 2, 2019
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid, Hope S Rugo, Sylvia Adams, et al.
ESMO Open
|
January 28, 2026
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer
K L Jhaveri, N M Iyengar, N C Turner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
Cora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Plos One
|
August 28, 2018
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, et al.
Journal of the National Cancer Institute
|
February 1, 2021
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study
Leisha A Emens, Luciana Molinero, Sherene Loi, et al.
Journal of Global Oncology
|
November 27, 2019
Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational Study
Max S Mano, Rafaela Gomes, Gustavo Werutsky, et al.
Page
of 19